Jaxwest7: Drug study: Effect of a novel compound (rosiglitazone) on diabetes in BKS.Cg-Dock7m +/+ Leprdb/J female mice (2009)

Jackson Laboratory   Yan Yang   With: Yang Y

Jaxwest7 downloads
Click on "Download" link or button below, to see the available downloads for this project.
Institutional authorship Jackson Laboratory     Lab web site
Investigators Yan Yang       The Jackson Laboratory,  Bar Harbor, ME
Participants Yang Y
ContactYan Yang     yan.yang@jax.org     Lab web site
Affiliated CenterJAX In Vivo Services
Project type One-strain study
MPD identifiersJaxwest7     MPD:307
Data changelog No updates/corrections.       Initial release date: 06/2009.
Formatted citation
Click above to copy-paste the entire citation for this MPD web page.

Purpose: The goal of the study was to test the efficacy of novel compounds (rosiglitazone) in a diabetic mouse model BKS.Cg-Dock7m +/+ Leprdb/J strain fed glucose.

By posting this data, JAX® In Vivo Services contributes to community research resources and fulfills an agreement with clients to make normative data public.

Investigator's notes and website:

Compound evaluation services: Obesity and type 2 diabetes

Available download:  


Data: Jaxwest7.xls